Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Apr 27, 2017
Insider Transaction Report
Form 4
LOSORDO DOUGLAS W
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2017-04-25$4.74/sh−224$1,062→ 25,942 total
Footnotes (1)
- [F1]Includes 13,300 shares of unvested restricted stock.